| Symbol | SERA |
|---|---|
| Name | SERA PROGNOSTICS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical Specialities |
| Address | 2749 EAST PARLEYS WAY,SUITE 200, SALT LAKE CITY, Utah, 84109, United States |
| Telephone | +1 801 990-0520 |
| Fax | — |
| — | |
| Website | https://www.seraprognostics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001534969 |
| Description | Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a womans individualized risk of premature birth, preeclampsia, and other pregnancy complications. Additional info from NASDAQ: |
(99% Neutral) SERA PROGNOSTICS, INC. (SERA) Announces Clinical Development Update
Read more(30% Negative) SERA PROGNOSTICS, INC. (SERA) Reports Q3 2026 Financial Results
Read moreSERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026
Read moreSERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026
Read moreNew Form SCHEDULE 13G/A - SERA PROGNOSTICS, INC. <b>Filed:</b> 2026-07-15 <b>AccNo:</b> 0001716774-26-000016 <b>Size:</b> 8 KB
Read morePRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT04301518 | Prematurity Risk Assessment Combined With Clinical Interventions for Improving … | Na | Preterm Labor | Active_Not_Recruiting | 2020-11-06 | 2026-12-30 | ClinicalTrials.gov |
| NCT03530332 | Prediction and Prevention of Preterm Birth (PREVENT-PTB Study) | Na | Preterm Birth | Terminated | 2018-05-14 | 2019-08-30 | ClinicalTrials.gov |
| NCT02787213 | A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor | — | Preterm Birth | Completed | 2016-08-01 | 2019-06-01 | ClinicalTrials.gov |
| NCT01371019 | Proteomic Assessment of Preterm Birth | — | Preterm Birth | Completed | 2011-04-01 | 2015-04-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| PreTRM test | Other | Approved | Preterm Birth | TERMINATED | NCT03530332 |
| Multimodal intervention strategy | Other | Approved | Preterm Labor | ACTIVE_NOT_RECRUITING | NCT04301518 |
| Multimodal intervention strategy | OTHER | Approved | Preterm Labor | ACTIVE_NOT_RECRUITING | NCT04301518 |